Podcasts about medical oncology

Branch of medicine dealing with cancer

  • 290PODCASTS
  • 909EPISODES
  • 28mAVG DURATION
  • 5WEEKLY NEW EPISODES
  • Jun 16, 2025LATEST
medical oncology

POPULARITY

20172018201920202021202220232024


Best podcasts about medical oncology

Show all podcasts related to medical oncology

Latest podcast episodes about medical oncology

Oncology for the Inquisitive Mind
162. ASCO 2025 - Genitourinary Cancers (Prostate) with Dr. Anthony Joshua

Oncology for the Inquisitive Mind

Play Episode Listen Later Jun 16, 2025 34:52


Today, we're joined by Professor Anthony Joshua, head of Medical Oncology at St. Vincent's Hospital, Sydney, and a global leader in prostate cancer and melanoma. In this episode, Professor Joshua discusses multiple trials including AMPLITUDE, advancing prostate cancer therapies; CAN 2409, exploring immunotherapy; ARANOTE, showing darolutamide's impact on progression-free survival; the prognostic significance of PSA 0.2; and the landmark STAMPEDE study. Join us for a deep dive into these game-changing studies. Let's begin! It's a jam-packed episode!Studies discussed in the episode:AMPLITUDECAN2409ARANOTESTAMPEDE*AND MORE!For more episodes, resources and blog posts, visit www.inquisitiveonc.comPlease find us on Twitter @InquisitiveOnc!If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.comArt courtesy of Taryn SilverMusic courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content. Hosted on Acast. See acast.com/privacy for more information.

QuadShot News Podcast
6.9.2025 - NIVONEWS

QuadShot News Podcast

Play Episode Listen Later Jun 9, 2025 10:21


Check out this week's QuadCast with many highlights from ASCO, including adding nivo to postop CRT in HNSCC, the benefits of immunotherapy in resected MMRd colon cancer, how SRS beat HA-WBRT, and more. Check out the website and subscribe to the newsletter! www.quadshotnews.com Founders & Lead Authors: Laura Dover & Caleb Dulaney Podcast Host: Sam Marcrom

Research To Practice | Oncology Videos
Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later Jun 2, 2025 47:56


Featuring perspectives from Dr Prithviraj Bose and Dr Andrew T Kuykendall, including the following topics: Systemic Mastocytosis — Dr Bose (0:00) Myelofibrosis — Dr Kuykendall (24:46) CME information and select publications

Hematologic Oncology Update
Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit

Hematologic Oncology Update

Play Episode Listen Later Jun 2, 2025 47:55


Clinical investigators discuss available data guiding the management of systemic mastocytosis and myelofibrosis.  CME information and select publications here.

Research To Practice | Oncology Videos
Hepatocellular Carcinoma — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later Jun 1, 2025 51:05


Featuring perspectives from Dr Thomas A Abrams and Dr Ahmed Omar Kaseb, including the following topics: Current Treatment for Advanced Hepatocellular Carcinoma (HCC) — Dr Abrams (0:00) Promising Novel Approaches to HCC Management — Dr Kaseb (33:46) CME information and select publications

Gastrointestinal Cancer Update
Hepatocellular Carcinoma — Fourth Annual National General Medical Oncology Summit

Gastrointestinal Cancer Update

Play Episode Listen Later Jun 1, 2025 51:04


Clinical investigators discuss available data guiding the management of hepatocellular carcinoma.  CME information and select publications here.

Gastrointestinal Cancer Update
Hepatocellular Carcinoma — Fourth Annual National General Medical Oncology Summit

Gastrointestinal Cancer Update

Play Episode Listen Later Jun 1, 2025 51:04


Clinical investigators discuss available data guiding the management of hepatocellular carcinoma.  CME information and select publications here.

Gastrointestinal Cancer Update
Hepatocellular Carcinoma — Fourth Annual National General Medical Oncology Summit

Gastrointestinal Cancer Update

Play Episode Listen Later Jun 1, 2025 51:04


Clinical investigators discuss available data guiding the management of hepatocellular carcinoma.  CME information and select publications here.

Research To Practice | Oncology Videos
Multiple Myeloma — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later May 31, 2025 50:41


Featuring perspectives from Dr Natalie S Callander and Dr Thomas Martin, including the following topics: Introduction (0:00) Current and Emerging Therapeutic Approaches for Multiple Myeloma — Dr Callander (4:42) CAR T-Cell Therapy, Bispecific Antibodies and Antibody-Drug Conjugates — Dr Martin (31:16) CME information and select publications

Hematologic Oncology Update
Multiple Myeloma — Fourth Annual National General Medical Oncology Summit

Hematologic Oncology Update

Play Episode Listen Later May 31, 2025 50:41


Clinical investigators discuss available data guiding the management of multiple myeloma.  CME information and select publications here.

Research To Practice | Oncology Videos
Gastroesophageal Cancer — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later May 26, 2025 52:33


Featuring perspectives from Dr Yelena Y Janjigian and Dr Samuel J Klempner, MD, including the following topics: Role of Immune Checkpoint Inhibitors in the Management of Gastroesophageal Cancers — Dr Janjigian (0:00) Available and Emerging Targeted Therapeutic Approaches for Gastroesophageal Cancers — Dr Klempner(28:38) CME information and select publications

Gastrointestinal Cancer Update
Gastroesophageal Cancer — Fourth Annual National General Medical Oncology Summit

Gastrointestinal Cancer Update

Play Episode Listen Later May 26, 2025 52:32


Clinical investigators discuss available data guiding the management of gastroesophageal cancer.  CME information and select publications here.

Gastrointestinal Cancer Update
Gastroesophageal Cancer — Fourth Annual National General Medical Oncology Summit

Gastrointestinal Cancer Update

Play Episode Listen Later May 26, 2025 52:32


Clinical investigators discuss available data guiding the management of gastroesophageal cancer.  CME information and select publications here.

Oncology Peer Review On-The-Go
S1 Ep163: Spotlighting Key Upcoming Presentations Across Oncology at ASCO 2025

Oncology Peer Review On-The-Go

Play Episode Listen Later May 26, 2025 10:42


Ahead of the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, CancerNetwork® spoke with a variety of oncology experts about the late-breaking abstracts, plenary sessions, and other key presentations that may shift the paradigm across different cancer care fields. They highlighted anticipated clinical trial results that may transform the standard of care for gynecologic malignancies, lung cancer, and other disease types. Rachel N. Grisham, MD, section head of Ovarian Cancer and director of Gynecologic Medical Oncology at MSK Westchester of Memorial Sloan Kettering Cancer Center, shared her anticipation of findings from the phase 3 ROSELLA trial (NCT05257408) assessing relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer. She stated she was excited to see if the data may represent a new opportunity for this patient population. Next, MinhTri Nguyen, MD, a medical oncologist and hematologist at Stanford Health Care, highlighted a few breast cancer presentations to look out for. These topics included a plenary session on data from the phase 3 SERENA-6 study (NCT04964934) evaluating camizestrant in combination with CDK4/6 inhibitors for those with hormone receptor–positive, HER2-negative advanced breast cancer harboring emergent ESR1 mutations. Additionally, Eric K. Singhi, MD, assistant professor in the Department of General Oncology in the Division of Cancer Medicine, and assistant professor in the Department of Thoracic/Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center, spoke about a range of potentially practice-changing results in the lung cancer field. For example, he described a session focused on primary results of the phase 3 IMforte trial (NCT05091567) assessing lurbinectedin (Zepzelca) plus atezolizumab (Tecentriq) for those with extensive-stage small cell lung cancer (ES-SCLC). According to Singhi, data from IMforte may shift the paradigm of maintenance therapy for this SCLC population. In the world of head and neck cancer, Douglas R. Adkins, MD, associate professor of Internal Medicine, Division of Oncology, Section of Medical Oncology at Washington University School of Medicine in St. Louis, Missouri, highlighted the session on the phase 3 NIVOPOSTOP GORTEC 2018-01 trial (NCT03576417). Investigators of this study evaluated nivolumab (Opdivo) in combination with chemoradiotherapy for those with resected head and neck squamous cell carcinoma. Adkins noted his excitement to see how these data may impact the standard of care, particularly for patients in Europe, where investigators conducted the study. As part of an Oncology Decoded discussion, Benjamin Garmezy, MD, the associate director of genitourinary research and executive cochair of the Genitourinary Cancer Research Executive Committee at Sarah Cannon Research Institute (SCRI) and medical oncologist at SCRI Oncology Partners specializing in genitourinary cancers, discussed key abstracts in bladder cancer. One specific presentation included additional findings from the phase 3 NIAGARA trial (NCT03732677), which may show how circulating tumor DNA can influence treatment decision-making regarding perioperative durvalumab (Imfinzi) for patients with muscle-invasive bladder cancer.

Gastrointestinal Cancer Update
Gastroesophageal Cancer — Fourth Annual National General Medical Oncology Summit

Gastrointestinal Cancer Update

Play Episode Listen Later May 26, 2025 52:32


Clinical investigators discuss available data guiding the management of gastroesophageal cancer.  CME information and select publications here.

TALRadio
Radiation Therapy Demystified What Patients Should Really Know | Special Interview With Dr.K.C.Goutham Reddy

TALRadio

Play Episode Listen Later May 24, 2025 36:16


Radiation Therapy can seem daunting, but it doesn't have to be. Tune in to TALRadio English on Spotify & Apple Podcasts for a compelling interview with Dr. K.C. Goutham Reddy, Senior Consultant Oncologist and Founder & Managing Director of Cancer Shield Pvt Ltd. With a rich background in Medical Oncology, Radiation Oncology, and Palliative Care, Dr. Reddy shares valuable insights into the role of radiation therapy in cancer treatment, addressing common myths, clinical facts, and patient-centered approaches. Hosted by Suhasini, this episode offers clarity and confidence to those facing cancer.Host : SuhasiniGuest : K.C.Goutham ReddyYou Can Reach K.C.Goutham Reddy @linkedin.com/in/k-c-goutham-reddy-534b183b#TALRadioEnglish #CancerCare #RadiationTherapy #Oncology #HealthcareLeadership #PatientSupport #TALHospitals #MedicalOncology #PalliativeCare #CancerAwareness #HolisticHealing #ClinicalInsight #TouchALife #TALRadio

Research To Practice | Oncology Videos
Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later May 22, 2025 49:02


Featuring perspectives from Dr Shilpa Gupta and Dr Jonathan E Rosenberg, including the following topics: Management of Nonmetastatic Urothelial Bladder Cancer (UBC) — Dr Gupta (0:00) Optimizing the Treatment of Metastatic UBC — Dr Rosenberg (21:52) CME information and select publications

Prostate Cancer Update
Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit

Prostate Cancer Update

Play Episode Listen Later May 22, 2025 49:01


Clinical investigators discuss available data guiding the management of urothelial bladder cancer.  CME information and select publications here.

Research To Practice | Oncology Videos
Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later May 21, 2025 49:14


Featuring perspectives from Dr Paul E Oberstein and Dr Philip A Philip, including the following topics: Selection and Sequencing of Therapy for Patients with Metastatic Pancreatic Adenocarcinoma (PAD) — Dr Oberstein (0:00) Biomarker-Based Strategies for Metastatic PAD; Novel Investigational Approaches — Dr Philip(30:57) CME information and select publications

Gastrointestinal Cancer Update
Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit

Gastrointestinal Cancer Update

Play Episode Listen Later May 21, 2025 49:14


Clinical investigators discuss available data guiding the management of pancreatic cancer.  CME information and select publications here.

Gastrointestinal Cancer Update
Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit

Gastrointestinal Cancer Update

Play Episode Listen Later May 21, 2025 49:14


Clinical investigators discuss available data guiding the management of pancreatic cancer.  CME information and select publications here.

Gastrointestinal Cancer Update
Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit

Gastrointestinal Cancer Update

Play Episode Listen Later May 21, 2025 49:14


Clinical investigators discuss available data guiding the management of pancreatic cancer.  CME information and select publications here.

OncLive® On Air
S13 Ep2: Tailored Treatment Approaches for Older Patients With Advanced HR+/HER2– Breast Cancer

OncLive® On Air

Play Episode Listen Later May 19, 2025 49:30


This featured podcast includes a discussion with 3 experts on managing patients with hormone receptor–positive/HER2-negative (HR+/HER2–) metastatic breast cancer (mBC) from a satellite symposium held in conjunction with the 42nd Annual Miami Breast Cancer Conference® in March 2025. In observational studies of treatment patterns in older women with mBC, approximately half of the patients were undertreated, and only half received a CDK4/6 inhibitor (CDK4/6i)-based regimen in the first-line setting. Reasons for undertreatment include concerns about the patient's age, perceived frailty, and underlying health issues. Aging is a heterogeneous process; older patients must receive individualized treatment that is not based solely on their age but on a comprehensive assessment that objectively assesses their overall health and ability to tolerate treatment. This program is designed to help clinicians assess the fitness of older patients with HR+/HER2– mBC, review the efficacy and safety of CDK4/6i in this patient population, and individualize treatment decision-making appropriately. Acknowledgment of Educational Grant Support This activity is supported by an educational grant from Pfizer Inc. Today's faculty are: Hope S. Rugo, MD Director, Women's Cancers Program Division Chief, Breast Medical Oncology Professor, Department of Medical Oncology & Therapeutics Research City of Hope Comprehensive Cancer Center Duarte, CA Professor Emeritus, UCSF Disclosures: Grant/Research Support: Ambrx; AstraZeneca; Daiichi Sankyo, Inc; F. Hoffmann-La Roche AG/Genentech, Inc; Gilead Sciences, Inc; Lilly; Merck & Co., Inc; Novartis Pharmaceuticals Corporation; OBI Pharma; Pfizer; Stemline Therapeutics. Consultant: Napo Therapeutics; Puma Biotechnology; Sanofi. Honoraria: Chugai; Mylan/Viatris. Neil M. Iyengar, MD Associate Attending, Breast Medicine Service Program Lead, MSK Healthy Living Department of Medicine Memorial Sloan Kettering Cancer Center Associate Professor of Medicine Weill Cornell Medical College New York, NY Disclosures: Consultant/Adviser: Arvinas, AstraZeneca, BD Life Sciences, Daiichi Sankyo, Genentech/Roche, Gilead, Menarini-Stemline, Novartis, Pfizer, Puma, Seagen, TerSera Therapeutics. Speaker: Cardinal Health, Curio Sciences, DAVA Oncology, IntrinsiQ Health. Editorial Position: npj Breast Cancer, Oncology®. Equity/Ownership: Complement Theory, Bettering Company. Research Support (to institution): American Cancer Society, Breast Cancer Research Foundation, Conquer Cancer Foundation, Kat's Ribbon of Hope, National Cancer Institute/National Institutes of Health. Contracted Research: Novartis, SynDevRx. Komal Jhaveri, MD, FACP Patricia and James Cayne Chair for Junior Faculty Associate Attending Physician, Breast Medicine Service and Early Drug Development Service Section Head, Endocrine Therapy Research Program Clinical Director, Early Drug Development Service Memorial Sloan Kettering Cancer Center Associate Professor of Clinical Medicine Weill Cornell Medical College New York, NY Disclosures: Consultant/Advisory Board: AbbVie Inc, AstraZeneca Pharmaceuticals LP, Blueprint Medicines, Bristol Myers Squibb, Daiichi Sankyo Inc, Eisai Inc, Genentech, a member of the Roche Group, Gilead Sciences Inc, Jounce Therapeutics, Loxo Oncology Inc, a wholly owned subsidiary of Eli Lilly & Company, Menarini Group, Novartis, Olema Oncology, Pfizer Inc, Scorpion Therapeutics, Seagen Inc, Stemline Therapeutics Inc, Sun Pharma Advanced Research Company Ltd, Taiho Oncology Inc. Research Funding: AstraZeneca Pharmaceuticals LP, Debiopharm, Genentech, a member of the Roche Group, Gilead Sciences Inc, Loxo Oncology Inc, a wholly owned subsidiary of Eli Lilly & Company, Merck, Novartis, Pfizer Inc, Puma Biotechnology Inc, Scorpion Therapeutics, Zymeworks Inc. The staff of Physicians' Education Resource®, LLC, have no relevant financial relationships with ineligible companies. PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process. Off-Label Disclosure and Disclaimer This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient's medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Chicago's Afternoon News with Steve Bertrand
What does President Biden's diagnosis mean?

Chicago's Afternoon News with Steve Bertrand

Play Episode Listen Later May 19, 2025


Fahad Faruqi, MD, Doctor of Hematology and Medical Oncology at Northwestern Medicine, joins Lisa Dent to discuss former President Biden’s prostate cancer diagnosis. Dr. Faruqi discusses the difference between ‘terminal’ and ‘incurable’ and what it means for Biden’s health.

Research To Practice | Oncology Videos
Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later May 18, 2025 50:15


Featuring perspectives from Dr Ramaswamy Govindan and Dr Stephen V Liu, including the following topics: Introduction (0:00) Management of Nonmetastatic Non-Small Cell Lung Cancer (NSCLC) without a Targetable Mutation — Dr Govindan (4:04) First- and Later-Line Therapy for Metastatic NSCLC without a Targetable Mutation — Dr Liu (26:59) CME information and select publications

Lung Cancer Update
Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit

Lung Cancer Update

Play Episode Listen Later May 18, 2025 50:15


Clinical investigators discuss available data guiding the management of non-small cell lung cancer with immunotherapy and other nontargeted approaches.  CME information and select publications here.

Research To Practice | Oncology Videos
Colorectal Cancer — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later May 17, 2025 50:09


Featuring perspectives from Dr Christopher Lieu and Dr Kanwal Raghav, including the following topics: Optimizing the Care of Patients with Nonmetastatic Colorectal Cancer (CRC) — Dr Lieu (0:00) Recent Advances in the Management of Metastatic CRC — Dr Raghav (32:58) CME information and select publications

Gastrointestinal Cancer Update
Colorectal Cancer — Fourth Annual National General Medical Oncology Summit

Gastrointestinal Cancer Update

Play Episode Listen Later May 17, 2025 50:09


Clinical investigators discuss available data guiding the management of colorectal cancer.  CME information and select publications here.

Gastrointestinal Cancer Update
Colorectal Cancer — Fourth Annual National General Medical Oncology Summit

Gastrointestinal Cancer Update

Play Episode Listen Later May 17, 2025 50:09


Clinical investigators discuss available data guiding the management of colorectal cancer.  CME information and select publications here.

Gastrointestinal Cancer Update
Colorectal Cancer — Fourth Annual National General Medical Oncology Summit

Gastrointestinal Cancer Update

Play Episode Listen Later May 17, 2025 50:09


Clinical investigators discuss available data guiding the management of colorectal cancer.  CME information and select publications here.

Research To Practice | Oncology Videos
Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later May 12, 2025 50:04


Featuring perspectives from Dr Christopher Flower and Dr Krish Patel, including the following topics: Role of Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies for Non-Hodgkin Lymphoma (NHL) — Dr Patel (0:00) Other Available and Emerging Novel Therapies for NHL — Dr Flowers (22:07) CME information and select publications

Hematologic Oncology Update
Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit

Hematologic Oncology Update

Play Episode Listen Later May 12, 2025 50:03


Clinical investigators discuss available data guiding the management of non-Hodgkin lymphoma.  CME information and select publications here.

The Breast Cancer Podcast
A Mother's Heart: Nurturing Others, Nourishing Herself

The Breast Cancer Podcast

Play Episode Listen Later May 11, 2025 32:12


On this Mother's dray, we honor the heart of every mother — the love she gives, the sacrifices she makes, and the quiet strength she carries every single day. But today, we also pause to ask: how can mothers take care of themselves? How can faith and medicine guide them to nurture not just others, but their own beautiful, essential selves? Whether you are a mother, lost a mother, hope to be one, or are simply someone who has been touched by the love of a mother, this episode is for you. Together, let's explore what it means to mother others — and to mother ourselves — through the lens of both faith and wellness.Please join my two special guests on the podcast:Dr. Shabana Dewani  is board certified in Medical Oncology, Hematology, and Internal Medicine—and a joy to listen to!  You'll be able to hear her passion for how takes care of herself and advocates for other mothers. Pastor Jennifer Jackson offers faith perspective and self care for women. She provides us her learnings as she went through her own breast cancer diagnosis.  She strives to help women through life, whether it's a book, her own radio show, or by mentoring them.  You'll be uplifted by our discussion with Jennifer she talks about what faith says about women taking care of themselves.Learn More About Jennifer Jackson here.InstagramFacebookIf you want to buy my book, click the link below.Their Legacy, Their Light She Carries: A Breast Surgeon's Mission to Serve and Inspire HopeStay Connected with Dr. Deepa Halaharvi:TikTok: @breastdoctorInstagram: @drdhalaharviTBCP Instagram: @thebreastcancerpodcastWebsite: https://drdeepahalaharvi.com/YouTube: https://www.youtube.com/@deepahalaharvi5917Instagram: @thebreastcancerpodcast

Research To Practice | Oncology Videos
Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later May 11, 2025 48:42


Featuring perspectives from Dr David M O'Malley and Dr Brian M Slomovitz, including the following topics: Ovarian Cancer; HER2-Directed Therapy for Advanced Gynecologic Cancers — Dr O'Malley (0:00) Endometrial Cancer and Cervical Cancer — Dr Slomovitz (23:38) CME information and select publications

Gynecologic Oncology Update
Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit

Gynecologic Oncology Update

Play Episode Listen Later May 11, 2025 48:41


Clinical investigators discuss available data guiding the management of gynecologic cancers.  CME information and select publications here.

D.O. or Do Not: The Osteopathic Physician's Journey for Premed & Medical Students
Episode 152: Dr. Anna Levy, D.O. - Hematology/ Oncology- Director of Hepato-billiary Malignancies at NorthWell Health!

D.O. or Do Not: The Osteopathic Physician's Journey for Premed & Medical Students

Play Episode Listen Later May 6, 2025 40:20


Send us a textIn today's episode we have the pleasure of speaking to Dr. Anna Levy, D.O.   Dr. Levy is an oncologist who works in the very specialized area of liver related cancers.  Dr. Levy is Medical Director of Hepatobiliary Malignancies and the Hepatic Artery Pump Infusion Program, based at the R.J. Zuckerberg Cancer Center.   Dr Levy is  is Board certified in Internal Medicine, Hematology, and Medical Oncology.  She is  Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health Medical School.  Dr. Levy earned her medical degree at the Lake Erie College of Osteopathic Medicine followed by an Internal Medicine Residency at the Christiana Care Health System and ultimately completed her fellowship in Medical Oncology and Hematology at the Long Island Jewish Medical Center.Dr. Levy will delve into the life of an oncologist and the difficulties treating very sick patients.  She will discuss the difficulties of work life balance and how her family and home life allow her to “keep her cup full."  Dr. Levy will discuss the problem of suicide, among physicians specifically among high stress professions such as Hematology/ Oncology.  Dr. Levy will share her journey which started as an emigre from the Ukraine.  She will tell us about her discovery of Osteopathic Medicine and how she developed a  love for oncology, a difficult and complex specialty.  Please join us in our discussion with this  remarkable physician. . . a discussion you won't want to miss!

OncLive® On Air
S12 Ep45: RP1 Plus Nivolumab Delivers Durable Responses in PD-1–Exposed Melanoma: With Anna C. Pavlick, BSN, MSc, DO, MBA

OncLive® On Air

Play Episode Listen Later May 5, 2025 10:56


In today's episode, supported by Replimune, we had the pleasure of speaking with Anna C. Pavlick, BSN, MSc, DO, MBA, about the use of RP1 plus nivolumab (Opdivo) for the treatment of patients with advanced melanoma. Dr Pavlick is a professor of medicine in the Division of Hematology & Medical Oncology at Weill Cornell Medicine in New York, New York; as well as the founding director of the Cutaneous Oncology Program at Weill Cornell Medicine and NewYork-Presbyterian. In our exclusive interview, Dr Pavlick discussed the rationale for investigating this combination in patients with advanced melanoma who have received prior immune checkpoint inhibition, key efficacy and safety findings from the phase 1/2 IGNYTE trial (NCT03767348), and where the future may be headed regarding the use of oncolytic viruses in melanoma.

Lung Cancer Update
EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit

Lung Cancer Update

Play Episode Listen Later Apr 30, 2025 52:17


Clinical investigators discuss available data guiding the management of EGFR mutation-positive non-small cell lung cancer.  CME information and select publications here.

Research To Practice | Oncology Videos
Prostate Cancer — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later Apr 29, 2025 47:34


Featuring perspectives from Dr Rahul Aggarwal and Dr William K Oh, including the following topics: Hormonal Therapy for Patients with Prostate Cancer — Dr Oh (0:00) Other Available and Emerging Therapeutic Approaches — Dr Aggarwal (27:14) CME information and select publications

Prostate Cancer Update
Prostate Cancer — Fourth Annual National General Medical Oncology Summit

Prostate Cancer Update

Play Episode Listen Later Apr 29, 2025 47:33


Clinical investigators discuss available data guiding the management of prostate cancers. CME information and select publications here.

Dr. Tamara Beckford Show
Charting Made Easy for Physicians

Dr. Tamara Beckford Show

Play Episode Listen Later Apr 28, 2025 38:30


Are you a physician overwhelmed by late-night charting? Dr. Mary Leung, board-certified in internal medicine, medical oncology, and hematology — and now a certified life coach — knows your struggle firsthand.Dr. Mary completed her medical education at the University at Buffalo School of Medicine. She went on to complete her residency in Internal Medicine and her fellowship in Hematology and Medical Oncology at the Zucker School of Medicine at Hofstra/Northwell. Her solid clinical background, combined with her experience as a certified life coach, gives her a unique and compassionate perspective on physician burnout and well-being.In this empowering livestream, discover how Dr. Mary went from burnout and after-hours charting to confidently finishing her clinical day on time. Learn the exact tools and mindset shifts that transformed her routine and helped her rediscover joy in medicine.✅ Why charting was draining her energy✅ How coaching transformed her time and mindset✅ How she helps physicians regain control, clarity, and time✅ Steps to build a meaningful, sustainable medical careerDr. Mary founded Shining With Gratitude MD to guide physicians through their unique journeys. Her mission: help doctors feel better, live fuller lives, and fall in love with medicine again.Connect with Dr. MaryLinkedIn Mary Leung, MDFacebook Mary LeungWebsite https://www.shiningwithgratitudemd.com

Research To Practice | Oncology Videos
Biliary Tract Cancers — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later Apr 27, 2025 48:55


Featuring perspectives from Dr Mitesh J Borad and Dr Amit Mahipal, including the following topics: Introduction (0:00) Targeted Therapeutic Approaches for Patients with Biliary Tract Cancers (BTCs) — Dr Mahipal (4:59) Integration of Immune Checkpoint Inhibitors into Current BTC Management — Dr Borad (32:16) CME information and select publications

Gastrointestinal Cancer Update
Biliary Tract Cancers — Fourth Annual National General Medical Oncology Summit

Gastrointestinal Cancer Update

Play Episode Listen Later Apr 27, 2025 48:54


Clinical investigators discuss available data guiding the management of biliary tract cancers.  CME information and select publications here.

Gastrointestinal Cancer Update
Biliary Tract Cancers — Fourth Annual National General Medical Oncology Summit

Gastrointestinal Cancer Update

Play Episode Listen Later Apr 27, 2025 48:54


Clinical investigators discuss available data guiding the management of biliary tract cancers.  CME information and select publications here.

Breast Cancer Update
HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

Breast Cancer Update

Play Episode Listen Later Apr 21, 2025 99:35


Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer.  CME information and select publications here.

Research To Practice | Oncology Videos
EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later Apr 20, 2025 52:18


Featuring perspectives from Dr Jonathan Goldman and Dr Natasha B Leighl, including the following topics: Introduction (0:00) Current Management of Nonmetastatic and Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) — Prof Leighl (1:42) Promising Novel Agents in Clinical Development; EGFR Exon 20 Mutation-Positive NSCLC — Dr Goldman (37:25) CME information and select publications

Research To Practice | Oncology Videos
HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later Apr 19, 2025 99:35


Featuring perspectives from Dr Aditya Bardia, Dr Virginia F Borges, Dr Harold J Burstein and Dr Joyce O'Shaughnessy, including the following topics: Introduction (0:00) HER2-Positive Breast Cancer — Dr O'Shaughnessy (3:13) Triple-Negative Breast Cancer — Dr Bardia (32:56) Personalizing Adjuvant Therapy for Patients with HR-Positive Breast Cancer — Dr Borges (57:35) Current Role of CDK4/6 Inhibitors in the Localized Setting — Dr Burstein (1:25:15) CME information and select publications

The Plant Free MD with Dr Anthony Chaffee: A Carnivore Podcast
Episode 275: Quantum Health Beyond Carnivore

The Plant Free MD with Dr Anthony Chaffee: A Carnivore Podcast

Play Episode Listen Later Apr 14, 2025 67:26


The premise behind the Carnivore Diet is to eat to our biological design: exposing ourselves to the beneficial and essential nutrients, and removing the harmful exposures.  However there are more essential and beneficial exposures beyond just meat, and there are harmful exposures besides plant toxins.  This episode takes a closer look beyond the best ditary exposures to what are some of the best overall exposures for your health as well.  Enjoy! Dr. Petra Davelaar is a naturopathic doctor specializing in Deutenomic medicine—a field that explores the role of deuterium (a heavy isotope of hydrogen) in human health. Her work focuses on how deuterium levels affect cellular processes, particularly mitochondrial function, and how reducing deuterium accumulation may support disease prevention and recovery. ​ Born and raised in the Netherlands, Dr. Davelaar moved to New York in her 20s. She earned her Doctor of Naturopathic Medicine degree from Bastyr University in California in 2016. After practicing in Santa Monica for several years, she now offers consultations via telemedicine. Since January 2021, her credentials have been recognized in Hungary and most other European countries. ​ Dr. Davelaar is also certified in functional medicine and nutrition. She has served as a peer reviewer for scientific journals such as Scientific Reports and Medical Oncology. ​ In addition to her clinical work, Dr. Davelaar has contributed to public education through lectures and podcasts, discussing topics like deuterium depletion, over-hydration, and their implications for health and disease. ​ For more information about her work or to schedule a consultation, you can visit her official website at drpetrad.com  

Research To Practice | Oncology Videos
Sarcoma and Other Connective Tissue Neoplasms — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later Apr 14, 2025 51:15


Featuring perspectives from Dr Rashmi Chugh and Dr Richard F Riedel, including the following topics: Other Connective Tissue Neoplasms — Dr Chugh (0:00) Sarcoma — Dr Riedel (28:16) CME information and select publications

Research To Practice | Oncology Videos
HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit

Research To Practice | Oncology Videos

Play Episode Listen Later Apr 13, 2025 119:30


Featuring perspectives from Dr Aditya Bardia, Dr Virginia F Borges, Dr Harold J Burstein and Dr Joyce O'Shaughnessy, including the following topics: Introduction (0:00) CDK4/6 Inhibitors for HR-Positive Metastatic Breast Cancer (mBC) — Dr Borges (9:56) Targeting the PTEN/PI3K/AKT Pathway in HR-Positive mBC — Dr Burstein (35:20) Role of Oral Selective Estrogen Receptor Degraders in the Management of HR-Positive mBC — Dr O'Shaughnessy (1:03:07) Antibody-Drug Conjugates for HR-Positive mBC — Dr Bardia (1:36:12) CME information and select publications